HOME >> MEDICINE >> NEWS
GroPep awarded key patent for infertility treatment in Europe

Adelaide biotechnology company, GroPep, has achieved a major development milestone in its infertility drug program with the granting of European patent number 1028743.

The patent covering GroPep's drug for the treatment of recurrent miscarriage provides the company with a European market patent exclusivity until at least 2018. GroPep already has two US patents covering the active ingredient of the drug until 2020.

According to the American College of Obstetricians and Gynecologists, at least 50 percent of recurrent miscarriages have no apparent explanation and there is no cure. The size of the market, the lack of competition and the strong patent position held by GroPep, means that the drug has the potential to participate in a market worth up to US$750 million annually.

Listed biopharmaceutical company GroPep Limited (ASX: GRO) today announced that European Patent No. 1028743, covering a method of treating recurrent miscarriage and preeclampsia using GroPep's infertility drug product - PV903, has been granted.

This patent grant is a major product development milestone as it provides the Company with a European market patent exclusivity until at least 2018. The European patent compliments two granted US patents licensed to GroPep by OSI Pharmaceuticals that cover the active ingredient of PV903 and method of manufacture until at least 2020. The combination provides GroPep with patent protection in the world's most valuable markets. The Company is also prosecuting additional patent applications to further extend the patent protection around PV903.

GroPep's Chief Executive Officer, Mr Bob Finder, said that the Company is developing PV903 as a potential treatment for recurrent miscarriage, a traumatic infertility condition with an estimated market potential of over US$750 million per year. There are currently no drugs approved for the treatment of recurrent miscarriage.

The European patent is owned by the Univers
'"/>

Contact: Tony Mitchell
61-88-354-7700
Research Australia
26-Jul-2006


Page: 1 2

Related medicine news :

1. GroPep starts Phase 1 infertility trial
2. GroPep completes final milestone of the path malaria vaccine initiative
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. LSUHSC awarded designation resulting in improved patient safety and outcomes
8. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
9. UIC awarded $7M NIH grant for infertility research
10. $2.6M grant awarded to New York University College of Nursing
11. Greenberg Prize awarded to Dr. Joseph G. Hayes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... ... A July 26 article on Reader’s Digest discusses how at least ... day. The acknowledges that, with dogs not always cooperating with being brushed, many owners ... least twice a week is likely enough to keep canines healthy. The article does ...
(Date:8/19/2019)... ... 18, 2019 , ... More Labs ( http://www.morelabs.com ), the ... SKUs to its line of functional offerings. Aqua+ is an oral rehydration solution ... Aqua+ from other rehydration solutions is the added benefits. On top of electrolytes, ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... Cannabinoid Biosciences ... non-pharmaceutical cannabidiol (CBD) products across the CBD market in the United States in ... campaign to raise $50 million on September 9, 2019. , Established on May ...
(Date:8/16/2019)... ... August 16, 2019 , ... The employees ... children’s aircraft to Ronald McDonald House Charities in New Hyde Park, Long Island, ... medical treatments and their family members a comfortable and fun way to watch ...
Breaking Medicine News(10 mins):
(Date:8/17/2019)... ... 17, 2019 , ... Inc. Magazine Unveils Its Annual List ... 2502 on the 2019 Inc. 5000 with Three-Year Revenue Growth of 157% Percent ... firm is No. 2502 on its annual Inc. 5000 list, the most prestigious ...
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center has ... Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The one-day ... Heights, is aimed at helping Houston families get their children caught up on ...
(Date:8/16/2019)... ... August 16, 2019 , ... Quantum Genomics are the creators ... hypertension by acting in the brain to interfere with the renin-angiotensin system. , ... affected by treatment-resistant hypertension, resulting in almost 10 million deaths per year from ...
Breaking Medicine Technology:
Cached News: